Literature DB >> 19305117

Limitations on work and attendance rates after employees with cancer returned to work at a single manufacturing company in Japan.

Takayuki Ohguri1, Rie Narai, Atsushi Funahashi, Chihiro Nishiura, Tsuyoshi Yamashita, Keiichiro Yarita, Yukunori Korogi.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate the work limitations and attendance rates after employees diagnosed with cancer returned to work from sick leave, and to identify the related factors for the limitations and attendance rates at a single manufacturing company in Japan.
METHODS: This study retrospectively analyzed 129 men and 4 women, employed in a single manufacturing industry, who returned to work after sick leave due to newly diagnosis of cancer. Limitations on work after the return to work were enforced in the workplace based on an industrial physician's evaluation. All the employees who needed measures for work were examined by the industrial physicians every 1-6 months until the termination of such work limitations.
RESULTS: Limitations on work after the return to work were enforced for 79 (59%) employees (36 employees with alteration of work, 31 with prohibition of shift work and 55 with prohibition of overtime work). A higher degree of work limitations was significantly correlated with work-related factors before sick leave (i.e. shift work, production line) as well as disease/treatment-related factors (i.e. chemotherapy, recurrence/metastasis), while the attendance rates after the return to work were not correlated with adverse work-related factors before sick leave.
CONCLUSION: The enforcement of work limitations for employees with cancer was relatively common and was based on both disease/treatment- and work-related factors, and this phenomenon may play an important role in the return to work as well as the successful continuation of work after cancer survivors return to work.

Entities:  

Mesh:

Year:  2009        PMID: 19305117     DOI: 10.1539/joh.o8013

Source DB:  PubMed          Journal:  J Occup Health        ISSN: 1341-9145            Impact factor:   2.708


  7 in total

1.  Prognostic factors of work disability in sick-listed cancer survivors.

Authors:  Peter van Muijen; Saskia F A Duijts; Allard J van der Beek; Johannes R Anema
Journal:  J Cancer Surviv       Date:  2013-06-26       Impact factor: 4.442

2.  Predictors of return to work in cancer survivors in the Royal Air Force.

Authors:  Kenneth Murray; Kin Bong Hubert Lam; David C McLoughlin; Steven S Sadhra
Journal:  J Occup Rehabil       Date:  2015-03

3.  Factors in Removing Job Restrictions for Cancer Survivors in the United Kingdom Royal Air Force.

Authors:  Kenneth Murray; Kin Bong Hubert Lam; David McLoughlin; Steven S Sadhra
Journal:  J Occup Rehabil       Date:  2019-03

4.  Effectiveness of a Tailored Work-Related Support Intervention for Patients Diagnosed with Gastrointestinal Cancer: A Multicenter Randomized Controlled Trial.

Authors:  M H W Frings-Dresen; A G E M de Boer; A C G N M Zaman; K M A J Tytgat; J H G Klinkenbijl; F C den Boer; M A Brink; J C Brinkhuis; D J Bruinvels; L C M Dol; P van Duijvendijk; P H J Hemmer; B Lamme; O J L Loosveld; M M Mok; T Rejda; H Rutten; A Schoorlemmer; D J Sonneveld; L P S Stassen; R P Veenstra; A van de Ven; E R Velzing
Journal:  J Occup Rehabil       Date:  2021-06

Review 5.  The global impact of non-communicable diseases on macro-economic productivity: a systematic review.

Authors:  Layal Chaker; Abby Falla; Sven J van der Lee; Taulant Muka; David Imo; Loes Jaspers; Veronica Colpani; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Raha Pazoki; Oscar H Franco
Journal:  Eur J Epidemiol       Date:  2015-04-03       Impact factor: 8.082

6.  Return to work after cancer treatment of gynecologic cancer in Japan.

Authors:  Keiichiro Nakamura; Hisashi Masuyama; Takeshi Nishida; Junko Haraga; Naoyuki Ida; Masayuki Saijo; Tomoko Haruma; Tomoyuki Kusumoto; Noriko Seki; Yuji Hiramatsu
Journal:  BMC Cancer       Date:  2016-07-29       Impact factor: 4.430

7.  Returning to work after sick leave due to cancer: a 365-day cohort study of Japanese cancer survivors.

Authors:  Motoki Endo; Yasuo Haruyama; Miyako Takahashi; Chihiro Nishiura; Noriko Kojimahara; Naohito Yamaguchi
Journal:  J Cancer Surviv       Date:  2015-08-30       Impact factor: 4.442

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.